ArticleACS chemical neuroscience2026
Profiling Endogenous Opioid Peptide Release from Adrenal Chromaffin Cells.
Article in ACS chemical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lessons from In Utero and Postnatal Exposure to Pesticide DDT: Mechanisms of Chromaffin Cell Vulnerability and Altered Catecholamine Homeostasis.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Despite longstanding recognition that the adrenal medulla is a major source of both catecholamines and opioid peptides, direct measurements of opioid peptide release kinetics─and characterization of the full complexity of the peptidergic forms released─remain under studied. Here, this gap is addressed by introducing a workflow that integrates real-time electrochemical detection of catecholamine (CA) and enkephalin (ENK) release kinetics with tandem mass spectrometry to profile opioid peptide signaling from adrenal chromaffin cells. Fast-scan cyclic voltammetry was used to quantitatively monitor the exocytotic release of ENK peptides and CA from large dense-core vesicles in single chromaffin cells. Interestingly, ENK release events were evident on two separate time scales. The first phase of release was consistent with the codetected CA signal, suggesting release from the same population of vesicles. A slower signal was also present, suggestive of a strong association with the dense-core matrix and hindered mass transport. Liquid chromatography was coupled with mass spectrometry (LC-MS) to profile the activity-dependent opioid peptide release from these cells. The MS data show that proenkephalin-derived peptides dominate the adrenal peptidome, and that extended variants of M-ENK that contain the YGGFM motif plus additional amino acids, including YGGFM-RF, YGGFM-RGL, peptide E, BAM-18 and BAM-22, are actively released in response to both chemical and electrical stimulation. Overall, the results of this study inform on the temporal complexity and chemical diversity of peptide participants in opioid signaling while highlighting a versatile and powerful workflow for further exploration of these molecules in physiological systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.